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Despite the effective anti-tuberculosis chemotherapy, TB remains one of the leading 
infectious diseases in many countries, including Kazakhstan. 
The whole genome sequencing of 20 M.tuberculosis clinical isolates from TB patients with 
different drug resistance (8 MDR, 4 XDR, 2 mono-resistant, 1 poly-resistant, 5 susceptible) were 
performed by NGS platform Roche 454 GS FLX+. 
Bioinformatics analysis was performed and showed that relative indicators of coverage of the 
20 M.tuberculosis strains were high enough and sufficient for further analysis. Alignment of 
received sequences was performed separately for each of the twenty clinical isolates. On average, 
among all isolates 97.8% sequences was mapped to the reference strain M.tuberculosis H37Rv that 
composed 4334396 nucleotide bases. Most of the studied isolates of M. tuberculosis (18) are 
Beijing family strains (East Asian), only two isolates belongs to families T (Euro-American) and 
MANU-1 (Indo-Oceanic). International «Tuberculosis Drug Resistance Mutation Database» was 
analyzed to study the genetic loci involved in the resistance to basic anti-TB drugs. As a result of 
the analysis the most common mutations in genetic loci associated with drug resistance to basic 
anti-TB drugs were selected. Genetic mutations in genes associated with drug resistance of 
M.tuberculosis were analyzed and found 18-27 genetic variants. Al l detected genomic variants with 
single nucleotide polymorphisms, insertions, deletions for each clinical isolates of M.tuberculosis 
indicating the description of the gene and protein, the positions on reference genome H37Rv, deep 
coverage of gene were prepared. Three main groups for comparative bioinformatic analysis were 
chosen - susceptible, MDR and XDR. 1018 genomic loci were identified as a common for all three 
study groups. The major parts of these genomic variants are found in "core" genes that necessary 
for mycobacteria life-sustaining activity. Several genomic variants have been detected in four genes 
PEPGRS24, PPE24, PPE5, PEPGRS56 which are typical for MDR and XDR isolates and belong 
to genes of protein family PE/PPE specific for species of Mycobacteria only. 
The mutations specific to MDR and XDR groups of M.tuberculosis isolates can be one of the 
additional virulence factors that may provide an advantage in host-pathogen interaction and require 
further investigation. 
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